Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

gamma-aminobutyric Acid (GABA) A Receptor, beta 2 (GABRB2) Peptide

GABRB2 Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN977214

Aperçu rapide pour gamma-aminobutyric Acid (GABA) A Receptor, beta 2 (GABRB2) Peptide (ABIN977214)

Antigène

GABRB2 (gamma-aminobutyric Acid (GABA) A Receptor, beta 2 (GABRB2))

Origine

Humain

Source

  • 8
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-GABRB2 antibody (Catalog #: ARP34989_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Indications d'application

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Conseil sur la manipulation

    Avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    GABRB2 (gamma-aminobutyric Acid (GABA) A Receptor, beta 2 (GABRB2))

    Sujet

    The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. GABRB2 encodes GABA A receptor, beta 2 subunit.

    Protein Interaction Partner: ARFGEF2,PPP3CA,PRKCB,TRAK2,TRAK2

    Protein Size: 474

    Poids moléculaire

    55 kDa

    ID gène

    2561

    NCBI Accession

    NM_000813, NP_000804

    UniProt

    P47870
Vous êtes ici:
Chat with us!